Taiko Pharmaceutical Co.,Ltd. (TYO:4574)

Taiko Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,666	4,256	4,532	5,484	3,105	5,796
Short-Term Investments	500	-	-	-	400	302
Cash & Short-Term Investments	3,166	4,256	4,532	5,484	3,505	6,098
Cash Growth	-23.51%	-6.09%	-17.36%	56.46%	-42.52%	23.34%
Receivables	1,934	2,450	2,428	1,985	1,798	4,056
Inventory	1,904	1,618	1,675	1,373	1,952	3,205
Other Current Assets	194	109	126	267	301	424
Total Current Assets	7,198	8,433	8,761	9,109	7,556	13,783
Property, Plant & Equipment	3,354	3,312	3,271	3,581	6,397	7,113
Long-Term Investments	502	269	747	526	867	1,338
Other Intangible Assets	36	34	27	1	222	299
Long-Term Deferred Tax Assets	-	221	105	1	2	-
Other Long-Term Assets	1	1	3	2	2	2
Total Assets	11,091	12,270	12,914	13,220	15,046	22,535

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	481	422	338	375	274	309
Accrued Expenses	115	247	176	75	23	149
Current Portion of Long-Term Debt	119	792	1,206	1,206	1,039	923
Current Portion of Leases	-	14	18	27	29	36
Current Income Taxes Payable	381	683	728	782	571	1,282
Other Current Liabilities	308	351	389	581	857	1,621
Total Current Liabilities	1,404	2,509	2,855	3,046	2,793	4,320
Long-Term Debt	-	-	792	1,999	2,720	3,760
Long-Term Leases	-	10	11	22	21	54
Pension & Post-Retirement Benefits	638	623	655	624	659	805
Long-Term Deferred Tax Liabilities	-	6	20	188	125	104
Other Long-Term Liabilities	624	605	618	603	685	686
Total Liabilities	2,666	3,753	4,951	6,482	7,003	9,729

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	10	10	10	2,267	1,201	1,201
Additional Paid-In Capital	4,960	4,978	4,997	2,689	1,642	1,648
Retained Earnings	3,328	3,450	2,526	1,628	5,239	10,134
Treasury Stock	-202	-237	-273	-300	-348	-388
Comprehensive Income & Other	329	316	703	454	309	211
Shareholders' Equity	8,425	8,517	7,963	6,738	8,043	12,806
Total Liabilities & Equity	11,091	12,270	12,914	13,220	15,046	22,535

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	119	816	2,027	3,254	3,809	4,773
Net Cash (Debt)	3,047	3,440	2,505	2,230	-304	1,325
Net Cash Growth	8.28%	37.33%	12.33%	-	-	-72.68%
Net Cash Per Share	60.62	68.48	49.92	47.09	-6.97	30.45
Filing Date Shares Outstanding	50.31	50.25	50.19	50.15	43.58	43.58
Total Common Shares Outstanding	50.31	50.25	50.19	49.95	43.58	43.58
Working Capital	5,794	5,924	5,906	6,063	4,763	9,463
Book Value Per Share	167.47	169.49	158.65	134.90	184.57	293.84
Tangible Book Value	8,389	8,483	7,936	6,737	7,821	12,507
Tangible Book Value Per Share	166.75	168.81	158.11	134.88	179.48	286.98

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error